Search
Now showing items 1-2 of 2
Flunixin pharmacokinetics and serum thromboxane inhibition in the dog
(1989)
Flunixin meglumine administered orally to beagle dogs at doses of 0.55, 1.10 or 1.65 mg/kg bodyweight was rapidly absorbed to produce maximum mean plasma concentrations of 2.40 +/- 0.70, 4.57 +/- 1.12 and 7.42 +/- 2.07 ...
Relay bioavailability and toxicity of isometamidium residues : a model for human risk assessment
(1989)
The bioavailability and potential toxicity of the residues of the antitrypanosomal drug isometamidium (ISMM) in bovine tissues were investigated in male Sprague-Dawley rats. They were allowed to feed for 7 and 21 days on ...